4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia

被引:30
|
作者
Binder, A.
Endler, G.
Mueller, M.
Mannhalter, C.
Zenz, W.
机构
[1] Med univ Graz, Dept Gen Paediat, A-8036 Graz, Austria
[2] Med Univ Vienna, Inst Clin Med, Vienna, Austria
[3] Med Univ Vienna, Chem Lab Diagnost, Vienna, Austria
关键词
disseminated intravascular coagulation; fibrinogen; meningococcal disease; PAI-1; platelet count; polymorphism;
D O I
10.1111/j.1538-7836.2007.02724.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Meningococcal disease may present as sepsis, meningitis or a combination of both. Impaired fibrinolysis and massive elevation of the plasminogen activator inhibitor-1 (PAI-1) is a characteristic feature of meningococcal sepsis. We and others have reported an association between mortality and the functional 4G/5G promoter polymorphism of the PAI-1 gene in children with meningococcal sepsis. Objective: Multicenter study to investigate the association of the 4G/5G PAI-1 polymorphism and disseminated intravascular coagulation (DIC) in children with meningococcal disease in a Central European population. Patients/Methods: Blood samples and clinical information of 326 previously healthy children with meningococcal infection were collected from 95 pediatric hospitals in Germany, Switzerland, Italy, and Austria from 2000 to 2002. Results: DIC, defined as platelet counts below 100 G L-1, increased D-dimer levels and prolonged prothrombin time, was significantly associated with the 4G4G genotype [31 of 63 (49%) vs. 55 of 175 (31%), P = 0.014], resulting in a hazard ratio (HR) of 1.5 (95% confidence interval 1.1-2.1) to develop DIC. Carriers of the 4G4G genotype showed significantly lower platelet counts (183 G L-1 vs. 227 G L-1, P = 0.009) on admission. Fibrinogen and C-reactive protein levels were not associated with the PAI-1 4G/5G polymorphism, nor were white blood cell counts. Conclusions: Our data show a correlation between the 4G4G genotype of the PAI-1 gene and development of DIC in meningococcal infection.
引用
收藏
页码:2049 / 2054
页数:6
相关论文
共 50 条
  • [1] 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia
    Geishofer, G
    Binder, A
    Müller, M
    Zöhrer, B
    Resch, B
    Müller, W
    Faber, J
    Finn, A
    Endler, G
    Mannhalter, C
    Zenz, W
    EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (08) : 486 - 490
  • [2] 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia
    Gotho Geishofer
    Alexander Binder
    Martin Müller
    Bettina Zöhrer
    Bernhard Resch
    Wilhelm Müller
    Jörg Faber
    Adam Finn
    Georg Endler
    Christine Mannhalter
    Werner Zenz
    European Journal of Pediatrics, 2005, 164 : 486 - 490
  • [3] Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: Relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome
    McCormack, LJ
    Nagi, DK
    Stickland, MH
    Mansfield, MW
    MohamedAli, V
    Yudkin, JS
    Knowler, WC
    Grant, PJ
    DIABETOLOGIA, 1996, 39 (12) : 1512 - 1518
  • [4] 4 G/4G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy
    Xue, Cheng
    Nie, Wei
    Zhou, Chenchen
    Yu, Fei
    Wang, Dong-Mei
    Dai, Bing
    Mei, Chang-Lin
    RENAL FAILURE, 2014, 36 (03) : 332 - 338
  • [5] No association of the plasminogen activator inhibitor-1 promoter 4G/5G polymorphism with inhibitor level during basal transcription in vitro
    Zhan, M
    Zhou, YL
    Han, ZC
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (04) : 400 - 404
  • [6] No Association of the Plasminogen Activator Inhibitor-1 Promoter 4G/5G Polymorphism with Inhibitor Level during Basal Transcription In Vitro
    Mei Zhan
    Yuling Zhou
    Zhong Chao Han
    International Journal of Hematology, 2004, 79 (4) : 400 - 404
  • [7] Plasminogen activator inhibitor-1 genotype 4G/5G associates with skin involvement in Armenian familial Mediterranean fever patients
    Kriegshauser, Gernot
    Hayrapetyan, Hasmik
    Oberkanins, Christian
    Sarkisian, Tamara
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (11) : 2555 - 2559
  • [8] Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population
    Sugano, T
    Tsuji, H
    Masuda, H
    Nakagawa, K
    Nishimura, H
    Kasahara, T
    Yoshizumi, M
    Nakahara, Y
    Kitamura, H
    Yamada, K
    Yoneda, M
    Maki, K
    Tatsumi, T
    Azuma, A
    Nakagawa, M
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (02) : 201 - 204
  • [9] The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media
    Emonts, Marieke
    Wiertsema, Selma P.
    Veenhoven, Reinier H.
    Houwing-Duistermaat, Jeanine J.
    Walraven, Vanessa
    de Groot, Ronald
    Hermans, Peter W. M.
    Sanders, Elisabeth A. M.
    PEDIATRICS, 2007, 120 (02) : E317 - E323
  • [10] A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis
    Grubic, N
    Stegnar, M
    Peternel, P
    Kaider, A
    Binder, BR
    THROMBOSIS RESEARCH, 1996, 84 (06) : 431 - 443